Breaking Boundaries of Science, Technology, Medicine, Art, and Healthcare Policy meeting being held in LA March 10-13
Brian Mehling, MD, founder and chief medical officer of BHI Therapeutic Sciences, will virtually present on three topics at the 19th Annual World Congress of Society for Brain Mapping and Therapeutics. The meeting, entitled Breaking Boundaries of Science, Technology, Medicine, Art, and Healthcare Policy, will be held at the Los Angeles Convention Center, March 10-13.
Dr. Mehling will speak on the following: Safety study of Cultured Wharton’s Jelly Mesenchymal Stem Cells, Umbilical cord-derived stem cell therapy for multiple sclerosis treatment – a single subject case study, and Mesenchymal stem cell therapy for drowning induced hypoxic brain injury – A pediatric case report study of recovery.
Dr. Mehling is a board-certified American orthopedic trauma surgeon, researcher, and philanthropist. He conducts research in regenerative medicine and stem cell science. He is also board-certified in anti-aging and regenerative medicine.
“We are focused on bringing advanced stem cell research within reach of a wider audience, “said Dr. Mehling. We support continued research into regenerative medicine,” he added. He and his colleagues are conducting clinical investigations to study adult stem cells in regenerative medicine research. These cellular products are investigational and have not been shown to be safe or effective for any disease or condition.
This program is jointly Sponsored by Johns Hopkins University School of Medicine and Saint Louis University School of Medicine for Continuing Medical Education (CME) including 700+ presentations (live and virtual),13 keynotes, three panel discussions, and two bio-skills labs (Brain and Spine).
BHI Therapeutic Sciences (BHITS) supports investigational research and education in stem cell and regenerative medicine using cord blood cells (those that are harvesting from an umbilical cord in the case of a C-Section, bringing no injury or risk to mother or baby).
Stem cells are a special kind of cell that is being studied in research for its potential role in tissue repair; stem cells are investigational and are not an approved treatment for any disease.
Media Contact
Doreen Santora 201-342-7662
[email protected]
